BioWorld MedTech

March 3, 2011

Heavy metal gives way to software in new products

VIENNA – The accent is on the soft side this year at the annual congress of the European Society of Radiology that opens here today. (Medical Device Daily) Read More

Study could give boost to personalized medicine

International report: GlaxoSmithKline to sell OmniPod pump in Canada

Washington roundup: Continuing resolution undercuts Senate patent reform discussion

Financings roundup: HealthSouth to initiate offering of senior notes

MDD's food for med-tech thought

Agreements/contracts: HDL partners with Gamma in diagnostic cardiac test

Med-Tech Notes

People in the News

Deals roundup: Physio-Control acquires Jolife, LUCAS system

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Feb. 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...